|
Volumn 13, Issue 69, 2004, Pages 3-4
|
Carglumic acid: An advance in rare urea cycle disorders
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 PHENYLBUTYRIC ACID;
ARGININE;
CARBAMIC ACID DERIVATIVE;
CARGLUMIC ACID;
CARNITINE;
GLUTAMATE ACETYLTRANSFERASE;
GLUTAMIC ACID DERIVATIVE;
UNCLASSIFIED DRUG;
ACYLTRANSFERASE;
ARYLBUTYRIC ACID DERIVATIVE;
BODY GROWTH;
BRONCHUS SECRETION;
CLINICAL TRIAL;
CRYING;
DRUG APPROVAL;
DRUG CHOICE;
DRUG INDICATION;
DRUG MARKETING;
DRUG MECHANISM;
DRUG SPECIFICITY;
ENZYME DEFICIENCY;
ENZYME REPLACEMENT;
FRANCE;
HUMAN;
HYPERAMMONEMIA;
HYPERTHERMIA;
INTRINSIC SYMPATHOMIMETIC ACTIVITY;
METABOLIC DISORDER;
OPTIMAL DRUG DOSE;
PSYCHOMOTOR DEVELOPMENT;
REVIEW;
SIDE EFFECT;
SWEATING;
TACHYCARDIA;
TERATOGENICITY;
UREA CYCLE;
ARTICLE;
BLOOD;
CHILD;
FEMALE;
INBORN ERROR OF METABOLISM;
MALE;
RETROSPECTIVE STUDY;
ACETYLTRANSFERASES;
CHILD;
DRUG APPROVAL;
FEMALE;
FRANCE;
GLUTAMATES;
HUMANS;
HYPERAMMONEMIA;
MALE;
METABOLISM, INBORN ERRORS;
PHENYLBUTYRATES;
RETROSPECTIVE STUDIES;
|
EID: 1842505453
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (9)
|